Mondelēz International has unveiled a new range of lower calories nougat bars coated in Cadbury chocolate, containing only 91 calories, dubbed Cadbury Delights.
The range of nougat bars, which features a soft nougat filling and caramel layer inside, comprises salted caramel, orange and caramel, and hazelnut and caramel flavors.
According to Abi Eayrs, brand manager for Cadbury Delights at Mondelēz International, consumers are increasingly looking for lower-calorie snacks where they don’t have to compromise on taste or satisfaction.
Eayrs added that the lower-calorie chocolate category is growing by over 21 percent annually and their new range of Cadbury Delights presents a huge opportunity for retailers and wholesalers to drive incremental sales.
Cadbury Delights will be sold by next month for an RRP of £1.99.


Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
South Korea Central Bank Signals Cautious Policy Amid Inflation and Middle East Tensions
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Oil Prices Slip Amid Iran Ceasefire Extension, Hormuz Disruptions Keep Markets Tense
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Oil Prices Surge as U.S.-Iran Tensions Escalate and Strait of Hormuz Closes
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
U.S. Stock Futures Fall as Iran Tensions Escalate and Oil Prices Surge
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 



